Cresco Labs Valuation
| CRLBF Stock | USD 0.92 0.02 2.13% |
Today, the firm appears to be overvalued. Cresco Labs shows a prevailing Real Value of $0.88 per share. The current price of the firm is $0.92. Our model approximates the value of Cresco Labs from analyzing the firm fundamentals such as profit margin of (0.08) %, and Return On Equity of -0.0635 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Cresco Labs' price fluctuation is abnormally volatile at this time. Calculation of the real value of Cresco Labs is based on 3 months time horizon. Increasing Cresco Labs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cresco otc stock is determined by what a typical buyer is willing to pay for full or partial control of Cresco Labs. Since Cresco Labs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cresco OTC Stock. However, Cresco Labs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.92 | Real 0.88 | Hype 0.92 | Naive 0.84 |
The real value of Cresco OTC Stock, also known as its intrinsic value, is the underlying worth of Cresco Labs OTC Stock, which is reflected in its stock price. It is based on Cresco Labs' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cresco Labs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cresco Labs helps investors to forecast how Cresco otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cresco Labs more accurately as focusing exclusively on Cresco Labs' fundamentals will not take into account other important factors: Cresco Labs Total Value Analysis
Cresco Labs is currently forecasted to have takeover price of 1.29 B with market capitalization of 545.97 M, debt of 465.08 M, and cash on hands of 130.04 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cresco Labs fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.29 B | 545.97 M | 465.08 M | 130.04 M |
Cresco Labs Investor Information
About 23.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cresco Labs recorded a loss per share of 1.15. The entity had not issued any dividends in recent years. The firm had 1:812 split on the 3rd of December 2018. Based on the key indicators related to Cresco Labs' liquidity, profitability, solvency, and operating efficiency, Cresco Labs is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.Cresco Labs Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cresco Labs has an asset utilization ratio of 46.15 percent. This implies that the OTC Stock is making $0.46 for each dollar of assets. An increasing asset utilization means that Cresco Labs is more efficient with each dollar of assets it utilizes for everyday operations.Cresco Labs Ownership Allocation
Cresco Labs holds a total of 280.99 Million outstanding shares. Cresco Labs retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cresco Labs Profitability Analysis
The company reported the revenue of 821.68 M. Net Loss for the year was (319.6 M) with profit before overhead, payroll, taxes, and interest of 429.79 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cresco Labs' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cresco Labs and how it compares across the competition.
About Cresco Labs Valuation
The otc valuation mechanism determines Cresco Labs' current worth on a weekly basis. Our valuation model uses a comparative analysis of Cresco Labs. We calculate exposure to Cresco Labs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cresco Labs's related companies.Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. The company was founded in 2013 and is headquartered in Chicago, Illinois. Cresco Labs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3300 people.
8 Steps to conduct Cresco Labs' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Cresco Labs' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cresco Labs' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cresco Labs' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cresco Labs' revenue streams: Identify Cresco Labs' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cresco Labs' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cresco Labs' growth potential: Evaluate Cresco Labs' management, business model, and growth potential.
- Determine Cresco Labs' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cresco Labs' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cresco Labs Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cresco Labs does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 273.9 M | |
| Forward Price Earnings | 113.6364 | |
| Retained Earnings | -841.9 M |
Complementary Tools for Cresco OTC Stock analysis
When running Cresco Labs' price analysis, check to measure Cresco Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cresco Labs is operating at the current time. Most of Cresco Labs' value examination focuses on studying past and present price action to predict the probability of Cresco Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cresco Labs' price. Additionally, you may evaluate how the addition of Cresco Labs to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |